Local kallikrein-kinin system is involved in podocyte apoptosis under diabetic conditions

Apoptosis

Volumn 16, Issue 5, 2011, Pages 478-490

  Kwak, Seung Jae ^a   Paeng, Jisun ^a   Kim, Do Hee ^a   Lee, Sun Ha ^a   Nam, Bo Young ^a   Kang, Hye Young ^a   Li, Jin Ji ^a,b   Jung, Dong Sub ^a   Han, Seung Hyeok ^a   Ryu, Dong Ryeol ^c   Park, Jung Tak ^a   Chang, Tae Ik ^a   Yoo, Tae Hyun ^a   Han, Dae Suk ^a   Kang, Shin Wook ^a  

^a Yonsei University College of Medicine   (South Korea)

^b YANBIAN UNIVERSITY   (China)

^c Ewha Womans University School of Medicine   (South Korea)

Author keywords

Apoptosis; Diabetic nephropathy; Kallikrein kinin system; p38 MAPK; Podocyte

Indexed keywords

ALBUMIN; BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; CASPASE 3; GLUCOSE; KALLIKREIN; KININOGEN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; GLOMERULUS; KALLIKREIN KININ SYSTEM; MALE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; URINARY EXCRETION;

ANIMALS; APOPTOSIS; BRADYKININ; CYTOPROTECTION; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; GENE EXPRESSION; GLUCOSE; KALLIKREIN-KININ SYSTEM; MALE; MICE; PODOCYTES; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 79955856377     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-011-0585-1     Document Type: Article

References (47)

1. H Pavenstadt W Kriz M Kretzler 2003 Cell biology of the glomerular podocyte Physiol Rev 83 253 307 12506131 1:CAS:528:DC%2BD3sXntlGgtw%3D%3D (Pubitemid 36459882)
2. K Tryggvason J Wartiovaara 2001 Molecular basis of glomerular permselectivity Curr Opin Nephrol Hypertens 10 543 549 11458036 10.1097/00041552-200107000-00009 1:STN:280:DC%2BD3MvgsFCrug%3D%3D (Pubitemid 32664707)
3. SJ Shankland 2006 The podocyte's response to injury: role in proteinuria and glomerulosclerosis Kidney Int 69 2131 2147 16688120 10.1038/sj.ki.5000410 1:CAS:528:DC%2BD28XlsVert70%3D (Pubitemid 43882099)
4. AJ Collins RN Foley C Herzog B Chavers D Gilbertson A Ishani, et al. 2011 US renal data system 2010 annual data report Am J Kidney Dis 57 Suppl e1 e526
5. VS Stel A Kramer C Zoccali KJ Jager 2009 The 2006 ERA-EDTA registry annual report: a precis J Nephrol 22 1 12 19229813
6. G Wolf S Chen FN Ziyadeh 2005 From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy Diabetes 54 1626 1634 15919782 10.2337/diabetes.54.6.1626 1:CAS:528:DC%2BD2MXltVaisbY%3D (Pubitemid 40770751)
7. DJ Leehey AK Singh N Alavi R Singh 2000 Role of angiotensin II in diabetic nephropathy Kidney Int 77 Suppl S93 S98 10.1046/j.1523-1755.2000.07715. x 1:CAS:528:DC%2BD3cXms1Oiu7o%3D
8. G Wolf U Butzmann UO Wenzel 2003 The renin-angiotensin system and progression of renal disease: from hemodynamics to cell biology Nephron Physiol 93 P3 P13 12411725 10.1159/000066656 1:CAS:528:DC%2BD38Xotl2ktrs%3D (Pubitemid 37499910)
9. G Wolf E Mueller RA Stahl FN Ziyadeh 1993 Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta J Clin Invest 92 1366 1372 7690779 10.1172/JCI116710 1:CAS:528:DyaK3sXms1egtbk%3D (Pubitemid 23273912)
10. PW Anderson YS Do WA Hsueh 1993 Angiotensin II causes mesangial cell hypertrophy Hypertension 21 29 35 8418021 1:CAS:528:DyaK3sXhs1Wlt7w%3D (Pubitemid 23006449)
11. AA Geisterfer MJ Peach GK Owens 1988 Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells Circ Res 62 749 756 3280155 1:CAS:528:DyaL1cXhvVSqtb4%3D
12. HH Hsu S Hoffmann N Endlich A Velic A Schwab T Weide, et al. 2008 Mechanisms of angiotensin II signaling on cytoskeleton of podocytes J Mol Med 86 1379 1394 18773185 10.1007/s00109-008-0399-y 1:CAS:528:DC%2BD1cXhsVCmsrzO
13. J Gloy A Henger KG Fischer R Nitschke M Bleich P Mundel, et al. 1998 Angiotensin II modulates cellular functions of podocytes Kidney Int 67 Suppl S168 S170 10.1046/j.1523-1755.1998.06736.x 1:CAS:528:DyaK1cXmtVaitrw%3D
14. RV Durvasula AT Petermann K Hiromura M Blonski J Pippin P Mundel, et al. 2004 Activation of a local tissue angiotensin system in podocytes by mechanical strain Kidney Int 65 30 39 14675034 10.1111/j.1523-1755.2004.00362.x 1:CAS:528:DC%2BD2cXmt1SqtA%3D%3D (Pubitemid 38037489)
15. EJ Lewis LG Hunsicker RP Bain RD Rohde 1993 The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The collaborative study group N Engl J Med 329 1456 1462 8413456 10.1056/NEJM199311113292004 1:STN:280:DyaK2c%2FhvFKitQ%3D%3D (Pubitemid 23335891)
16. C Hill A Logan C Smith H Gronbaek A Flyvbjerg 2001 Angiotensin converting enzyme inhibitor suppresses glomerular transforming growth factor beta receptor expression in experimental diabetes in rats Diabetologia 44 495 500 11357481 10.1007/s001250051648 1:CAS:528:DC%2BD3MXit1GitbY%3D (Pubitemid 32324361)
17. ML Gross A El-Shakmak A Szabo A Koch A Kuhlmann K Munter, et al. 2003 ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy Diabetologia 46 856 868 12802493 10.1007/s00125-003- 1106-8 1:CAS:528:DC%2BD3sXkvFyjtr4%3D (Pubitemid 36831416)
18. C Tschope U Seidl A Reinecke U Riester K Graf HP Schultheiss, et al. 2003 Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy Int Immunopharmacol 3 335 344 12639811 10.1016/S1567-5769(02)00273-4 1:CAS:528:DC%2BD3sXhvFGktb8%3D (Pubitemid 36293962)
19. J Allard M Buleon E Cellier I Renaud C Pecher F Praddaude, et al. 2007 ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats Am J Physiol Renal Physiol 293 F1083 F1092 17596523 10.1152/ajprenal.00401.2006 1:CAS:528:DC%2BD2sXht1Wlu7nN (Pubitemid 47583940)
20. M Buleon J Allard A Jaafar F Praddaude Z Dickson MT Ranera, et al. 2008 Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model Am J Physiol Renal Physiol 294 F1249 F1256 18367657 10.1152/ajprenal.00501.2007 1:CAS:528:DC%2BD1cXmtVWnu7w%3D
21. KD Bhoola CD Figueroa K Worthy 1992 Bioregulation of kinins: kallikreins, kininogens, and kininases Pharmacol Rev 44 1 80 1313585 1:CAS:528: DyaK38XktVSqtLw%3D
22. HM Siragy 1993 Evidence that intrarenal bradykinin plays a role in regulation of renal function Am J Physiol 265 E648 E654 8238340 1:CAS:528:DyaK2cXhsVGr
23. B Shen SS El-Dahr 2006 Cross-talk of the renin-angiotensin and kallikrein-kinin systems Biol Chem 387 145 150 16497145 10.1515/BC.2006.019 1:CAS:528:DC%2BD28XitF2lsro%3D (Pubitemid 43221826)
24. J Chao HJ Li YY Yao B Shen L Gao G Bledsoe, et al. 2007 Kinin infusion prevents renal inflammation, apoptosis, and fibrosis via inhibition of oxidative stress and mitogen-activated protein kinase activity Hypertension 49 490 497 17224475 10.1161/01.HYP.0000255925.01707.eb 1:CAS:528:DC%2BD2sXhsVSitbk%3D
25. S Bodin C Chollet N Goncalves-Mendes J Gardes F Pean D Heudes, et al. 2009 Kallikrein protects against microalbuminuria in experimental type I diabetes Kidney Int 76 395 403 19516248 10.1038/ki.2009.208 1:CAS:528: DC%2BD1MXpsVKnurs%3D
26. M Kakoki N Takahashi JC Jennette O Smithies 2004 Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor Proc Natl Acad Sci USA 101 13302 13305 15326315 10.1073/pnas.0405449101 1:CAS:528: DC%2BD2cXnvFems7w%3D (Pubitemid 39209660)
27. Y Tan JS Keum B Wang MB McHenry SR Lipsitz AA Jaffa 2007 Targeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy Am J Physiol Renal Physiol 293 F1026 F1035 17596525 10.1152/ajprenal.00203.2007 1:CAS:528:DC%2BD2sXht1Wlu7jJ (Pubitemid 47583934)
28. P Mundel J Reiser A Zuniga Mejia Borja H Pavenstadt GR Davidson W Kriz, et al. 1997 Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines Exp Cell Res 236 248 258 9344605 10.1006/excr.1997.3739 1:CAS:528:DyaK2sXms1Grsr0%3D (Pubitemid 27452369)
29. ZG Xu TH Yoo DR Ryu H Cheon Park SK Ha DS Han, et al. 2005 Angiotensin II receptor blocker inhibits p27kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli Kidney Int 67 944 952 15698433 10.1111/j.1523-1755. 2005.00158.x 1:CAS:528:DC%2BD2MXis1Grur8%3D (Pubitemid 41623318)
30. K Tomita JJ Pisano 1984 Binding of [3h]bradykinin in isolated nephron segments of the rabbit Am J Physiol 246 F732 F737 6326616 1:CAS:528: DyaL2cXktleru7o%3D
31. C Tschope A Reinecke U Seidl M Yu V Gavriluk U Riester, et al. 1999 Functional, biochemical, and molecular investigations of renal kallikrein-kinin system in diabetic rats Am J Physiol 277 H2333 H2340 10600853 1:CAS:528:DC%2BD3cXps1Sq
32. NB Oza JH Schwartz HD Goud NG Levinsky 1990 Rat aortic smooth muscle cells in culture express kallikrein, kininogen, and bradykininase activity J Clin Invest 85 597 600 2298924 10.1172/JCI114479 1:CAS:528:DyaK3cXhtleis78%3D (Pubitemid 20070072)
33. S Hammerschmidt H Kuhn C Gessner HJ Seyfarth H Wirtz 2007 Stretch-induced alveolar type II cell apoptosis: role of endogenous bradykinin and PI3K-Akt signaling Am J Respir Cell Mol Biol 37 699 705 17630321 10.1165/rcmb.2006-0429OC 1:CAS:528:DC%2BD2sXhsVahurzL (Pubitemid 350211640)
34. S Naicker S Naidoo R Ramsaroop D Moodley K Bhoola 1999 Tissue kallikrein and kinins in renal disease Immunopharmacology 44 183 192 10604543 10.1016/S0162-3109(99)00089-2 1:CAS:528:DyaK1MXotVKqsLk%3D
35. C Tschope M Yu A Reinecke T Csikos U Hilgenfeldt JB Pesquero, et al. 1997 Renal expression of two rat kallikrein genes under diabetic conditions J Hypertens 15 1711 1714 9488227 10.1097/00004872-199715120-00077 1:CAS:528:DyaK1cXoslejsQ%3D%3D (Pubitemid 28029669)
36. AA Jaffa KX Chai J Chao L Chao RK Mayfield 1992 Effects of diabetes and insulin on expression of kallikrein and renin genes in the kidney Kidney Int 41 789 795 1513101 10.1038/ki.1992.122 1:CAS:528:DyaK38XksVGrt70%3D
37. JY Moon KH Jeong SH Lee TW Lee CG Ihm SJ Lim 2008 Renal ACE and ACE2 expression in early diabetic rats Nephron Exp Nephrol 110 e8 e16 18679036 10.1159/000149586 1:CAS:528:DC%2BD1cXhtFCis7jM
38. JJ Li SJ Kwak DS Jung JJ Kim TH Yoo DR Ryu, et al. 2007 Podocyte biology in diabetic nephropathy Kidney Int 106 Suppl S36 S42 10.1038/sj.ki.5002384 1:CAS:528:DC%2BD2sXotFylt78%3D (Pubitemid 47172559)
39. TH Yoo JJ Li JJ Kim DS Jung SJ Kwak DR Ryu, et al. 2007 Activation of the renin-angiotensin system within podocytes in diabetes Kidney Int 71 1019 1027 17361112 10.1038/sj.ki.5002195 1:CAS:528:DC%2BD2sXltVKjsLg%3D (Pubitemid 46741993)
40. JJ Zhang G Bledsoe K Kato L Chao J Chao 2004 Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress Kidney Int 66 722 732 15253727 10.1111/j.1523-1755.2004.00794.x 1:CAS:528:DC%2BD2cXmvVegsbc%3D (Pubitemid 38982016)
41. S Colie C Pecher JP Girolami N Blaes 2008 Modulation by bradykinin and nitric oxide of angiotensin II-induced apoptosis in a vascular smooth muscle cell phenotype Int Immunopharmacol 8 231 236 18182232 10.1016/j.intimp.2007.09. 006 1:CAS:528:DC%2BD1cXisFygsw%3D%3D
42. G Bledsoe B Shen YY Yao M Hagiwara B Mizell M Teuton, et al. 2008 Role of tissue kallikrein in prevention and recovery of gentamicin-induced renal injury Toxicol Sci 102 433 443 18227104 10.1093/toxsci/kfn008 1:CAS:528: DC%2BD1cXjtFOnt7s%3D (Pubitemid 351404913)
43. M Kakoki RW McGarrah HS Kim O Smithies 2007 Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury Proc Natl Acad Sci USA 104 7576 7581 17452647 10.1073/pnas.0701617104 1:CAS:528:DC%2BD2sXlslWqtLo%3D (Pubitemid 47185948)
44. YY Yao H Yin B Shen L Chao J Chao 2007 Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction Regul Pept 140 12 20 17196272 10.1016/j.regpep.2006.11.020 1:CAS:528:DC%2BD2sXitFOiu7w%3D (Pubitemid 46275053)
45. SW Kang SG Adler J Lapage R Natarajan 2001 p38 MAPK and MAPK kinase 3/6 mRNA and activities are increased in early diabetic glomeruli Kidney Int 60 543 552 11473637 10.1046/j.1523-1755.2001.060002543.x 1:CAS:528:DC%2BD3MXmtVOnsbY%3D (Pubitemid 32678898)
46. DS Jung JJ Li SJ Kwak SH Lee J Park YS Song, et al. 2008 FR167653 inhibits fibronectin expression and apoptosis in diabetic glomeruli and in high-glucose-stimulated mesangial cells Am J Physiol Renal Physiol 295 F595 F604 18524857 10.1152/ajprenal.00624.2007 1:CAS:528:DC%2BD1cXhtVaktLzE
47. M Schiffer M Bitzer IS Roberts JB Kopp P ten Dijke P Mundel, et al. 2001 Apoptosis in podocytes induced by TGF-beta and smad7 J Clin Invest 108 807 816 11560950 1:CAS:528:DC%2BD3MXmvV2ntLg%3D (Pubitemid 32880291)